Ascelia Pharma AB (publ) (STO:ACE)
Sweden · Delayed Price · Currency is SEK 3.040
+0.055 (1.84%)
Apr 14, 2026, 5:29 PM CET
Ascelia Pharma AB Market Cap
Ascelia Pharma AB has a market cap or net worth of 378.7 million as of April 14, 2026. Its market cap has increased by 34.95% in one year.
Market Cap
378.70M
Enterprise Value
329.81M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.04
Market Cap Chart
Since March 13, 2019, Ascelia Pharma AB's market cap has decreased from 562.35M to 378.70M, a decrease of -32.66%. That is a compound annual growth rate of -5.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 385.68M | -5.44% |
| Dec 30, 2025 | 407.88M | 45.35% |
| Dec 30, 2024 | 280.63M | 146.68% |
| Dec 29, 2023 | 113.76M | -77.38% |
| Dec 30, 2022 | 503.00M | -49.95% |
| Dec 30, 2021 | 1.00B | -36.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FluoGuide | 632.72M |
| Oncopeptides AB | 534.43M |
| Corline Biomedical AB | 411.10M |
| Sprint Bioscience AB | 386.19M |
| Bio-Works Technologies AB | 344.01M |
| Mendus AB | 306.74M |
| Intervacc AB | 285.94M |
| Elicera Therapeutics AB | 274.23M |